Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting

International Journal of Mycobacteriology

Volumn 2, Issue 2, 2013, Pages 103-108

  Eliseev, Platon I ^a   Maryandyshev, Andrey O ^a   Nikishova, Elena I ^a   Tarasova, Irina V ^b   Gorina, Galina P ^b   Chryssanthou, Erja ^c   Ridell, Malin ^d   Larsson, Lars Olof ^c  

^a NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Regional Clinical Antituberculosis Dispensary ^*  (Russian Federation)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Method evaluation; Rapid detection of MDR TB; Russia; Tuberculosis epidemiology

Indexed keywords

CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHILD; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RUSSIAN FEDERATION; SCHOOL CHILD; SPUTUM ANALYSIS; TUBERCULOSIS;

EID: 84887213248     PISSN: 22125531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2013.04.002     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis control WHO report, 2011.
2. World Health Organization multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response, WHO, 2010.
3. Mäkinen J., Marjamäki M., Haanperä-Heikkinen M., Marttila H., et al. Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30:1119-1126.
4. Casali N., Nikolayevskyy V., Balabanova Y., Ignatyeva O., et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 2012, 22:735-745.
5. Toungoussova O.S., Nizovtseva N.I., Mariandyshev A.O., Caugant D.A., et al. Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel Oblast, Russia in 1999. Euro. J. Clin. Microbiol. Infec. Dis. 2004, 23:174-179.
6. Balabanova Y., Nikolayevskyy V., Ignatyeva O., Kontsevaya I., et al. Survival of civilian and prisoner drug-sensitive, multi- and extensive drug-resistant tuberculosis cohorts prospectively followed in Russia. PLoS One 2011, 6(6):e20531. Epub 2011 Jun 10.
7. Ardito F., Posteraro B., Sanguinetti M., Zanetti S., Fadda G. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2001, 39:4440-4444.
8. Bemer P., Palicova F., Rüsch-Gerdes S., Drugeon H.B., Pfyffer G.E. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2002, 40:150-154.
9. Ling D.I., Zwerling A.A., Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Resp. J. 2008, 32:1165-1174.
10. Bwanga F., Hoffner S., Haile M., Joloba M.L. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 2009, 9:67.
11. Nikolayevskyy V., Balabanova Y., Simak T., Malomanova N., et al. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 2009, 9:2.
12. Chryssanthou E., Ängeby K. The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden. APMIS 2012, 120:405-409.
13. World Health Organization Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-resistant Tuberculosis (MDR-TB), Policy statement, WHO, 2008.
14. Mironova S., Pimkina E., Kontsevaya I., Nikolayevskyy V., et al. Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:1381-1387.
15. Dinic L., Akande P., Idigbe E.O., Ani A., et al. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria. J. Clin. Microbiol. 2012, 50:2905-2909.
16. Ocheretina O., Morose W., Gauthier M., Joseph P., et al. Multidrug-resistant tuberculosis in Port-au-Prince, Haiti. Rev. Panam. Salud Publica. 2012, 31:221-224.
17. Asencios L., Galarza M., Quispe N., Vásquez L., et al. [Molecular test Genotype® MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis]. Rev. Peru. Med. Exp. Salud Publica. 2012, 29:92-98.
18. Raveendran R., Wattal C., Oberoi J.K., Goel N., et al. Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India. Indian J. Med. Microbiol. 2012, 30:58-63.
19. Zignol M., Gemert W., Falzon D., Sismanidis C., et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull. World Health Organiz. 2012, 90:111-119.
20. Perelman M.I. Tuberculosis in Russia. Int. J. Tuberc. Lung Dis. 2000, 4:1097-1103.
21. Grange J.M. Mycobacteria and Human Disease 1996, Oxford University Press.
22. Siddiqi S.H., Rüsch-Gerdes S. Procedure manual For BACTEC MGIT 960 TB System. FIND 2007.
23. Canetti G., Froman S., Grosset J., Haudrey P., et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. WHO 1963, 29:565-578.
24. Tuberculosis in Russian Federation, 2010. Analytical overview of statistical rates used in Russian federation Published by the Ministry of Health of the Russian federation, 2011, (in Russian).
25. Antoine D., Maquire H., Story A. Epidemiology and responses to the growing problems of tuberculosis in London. Euro Surveill. 2006, 11:25-28.
26. Koshcheyev M.E., Galimov S.A., Yu E., et al. Tuberculosis epidemiology in Irkutsk region. Bull. Acad. Sci. Prophylactic Med. 2011, 78:138-142. (in Russian).
27. Punga V.V., Jakubowaik W.M., Danilova I.D., et al. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia. Int. J. Tuberc. Lung. Dis. 2009, 13:1309-1312.
28. Toungoussova O.S., Sandven P., Mariandyshev A.O., Nizovtseva N.I., et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 2002, 40:1930-1937.
29. Chernyaeva E., Dobrynin P., Pestova N., Matveeva N., et al. Molecular genetic analysis of Mycobacterium tuberculosis strains spread in different patient groups in St. Petersburg, Russia. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:1753-1757.
30. Svensson E., Millet J., Lindqvist A., Olsson M., et al. Impact of immigration on tuberculosis epidemiology in a low burden country. Clin. Microbiol. Infect. 2011, 17:881-887.
31. Lobacheva T., Sazhin V., Vdovichenko E., Giesecke J. Pulmonary tuberculosis in two remand prisons (SIZOs) in St. Petersburg, Russia. Euro. Surveill. 2005, 10:93-96.
32. Lobacheva T., Asikainen T., Giesecke J. Risk factors for developing tuberculosis in remand prisons in St. Petersburg, Russia - a case-control study. Eur. J. Epidemiol. 2007, 22:121-127.
33. Ruddy M., Balabanova Y., Graham C., Fedorin I., et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005, 60:130-135.
34. Mukinda F.K., Theron D., van der Spuy G.D., Jacobson K.R., et al. Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int. J. Tuberc. Lung Dis. 2012, 16:196-202.
35. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2011.6.